Dr. Jeffrey Goldberg

Biography

Jeffrey Goldberg is the Blumenkranz Smead Professor of Ophthalmology at Stanford University, where he also serves as the Chair of the Department of Ophthalmology and Director of the Byers Eye Institute. His clinical focus is on glaucoma, and he leads a research laboratory funded by the NIH dedicated to neuroprotection and regeneration of retinal ganglion cells and the optic nerve. With a goal to translate scientific discoveries into patient therapies, Dr. Goldberg's work includes developing novel stem cell and nanotherapeutic approaches for eye repair. He has received a degree of Doctor of Medicine and a Ph.D. in Neurosciences from Stanford University and completed his residency and fellowship at the Bascom Palmer Eye Institute. His contributions to the field have earned him notable recognitions, including being named Scientist of the Year by the Hope for Vision Foundation in 2010 and receiving the Cogan Award from the Association for Research in Vision and Ophthalmology in 2012. Dr. Goldberg is a member of the National Academy of Medicine and the American Society for Clinical Investigation, demonstrating his commitment to advancing the field of ophthalmology. He is actively involved in clinical trials and has expertise in implementing FDA IND clinical trials related to optic nerve neuroprotection and regeneration. His research also explores molecular mechanisms of survival and visual system regeneration, retinal development, and the use of nanoparticles in tissue engineering. Dr. Goldberg directs multiple clinical trials aiming to investigate innovative treatments for glaucoma and other optic neuropathies.

Research Interests

Experience

Courses